First-generation synthetic ghrelin/GHSR-1a agonist
PRODUCT PROFILE
GHRP-6 Acetate
Price range: £19.99 through £39.99
GHRP-6 is first-generation synthetic ghrelin/ghsr-1a agonist. Researchers examine it in relation to gh release alongside ghrelin-linked appetite and energy-intake signalling.
Its prominent appetite/ghrelin research profile distinguishes it from the more selective ipamorelin.
- Evidence stageEarly human evidence
- AvailabilityAvailable · 10 in stock
- Batch recordPublished after verification
- DispatchConfirmed at checkout
PRODUCT INFORMATION
Clear first. Detailed when needed.
What this material is+
GHRP-6 is first-generation synthetic ghrelin/ghsr-1a agonist. Researchers examine it in relation to gh release alongside ghrelin-linked appetite and energy-intake signalling.
Research focus+
Researchers study its effects on short growth-hormone pulses and appetite signalling. It is especially distinct because hunger-related effects are often part of the research discussion.
How the mechanism differs+
Activates GHSR-1a in pituitary and hypothalamic pathways, linking GH secretion with orexigenic signalling.
Evidence and limitations+
Human endocrine challenge studies exist; evidence for broader marketed outcomes is not established.
Testing and batch documentation+
No live certificate is shown for this staging item. ADINA will only publish a batch document after the product identifier, test method and result have been checked.
RESEARCH PROFILE
Understand the distinction.
Researchers study its effects on short growth-hormone pulses and appetite signalling. It is especially distinct because hunger-related effects are often part of the research discussion.
Activates GHSR-1a in pituitary and hypothalamic pathways, linking GH secretion with orexigenic signalling.
Its prominent appetite/ghrelin research profile distinguishes it from the more selective ipamorelin.
Human endocrine challenge studies exist; evidence for broader marketed outcomes is not established.
Educational research context only. This information is not dosage, administration or personal-use guidance.






